{
    "clinical_study": {
        "@rank": "110964", 
        "arm_group": [
            {
                "arm_group_label": "AOC group", 
                "arm_group_type": "Experimental", 
                "description": "AOC group: treated with amoxicillin, rabeprazole, clarithromycin for 7 days"
            }, 
            {
                "arm_group_label": "AOM group", 
                "arm_group_type": "Experimental", 
                "description": "AOM group: treated with amoxicillin, rabeprazole, metronidazole for 7 days"
            }, 
            {
                "arm_group_label": "Sequential group", 
                "arm_group_type": "Experimental", 
                "description": "Sequential group: treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days"
            }, 
            {
                "arm_group_label": "concomitant group", 
                "arm_group_type": "Experimental", 
                "description": "concomitant group: treated with amoxicillin, clarithromycin, metronidazole, rabeprazole for 7 days"
            }
        ], 
        "brief_summary": {
            "textblock": "If we compare eradication rate of Helicobacter pylori divided to 4 groups: amoxicillin,\n      rabeprazole, clarithromycin(AOC), amoxicillin, rabeprazole, metronidazole(AOM), treated with\n      amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole\n      for 5 days(sequential), amoxicillin, clarithromycin, metronidazole,\n      rabeprazole(concomitant), then the eradication rate of concomitant group will be the\n      highest."
        }, 
        "brief_title": "Concomitant Therapy of H. Pylori", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastritis, Gastric Ulcer, and Duodenal Ulcer", 
        "condition_browse": {
            "mesh_term": [
                "Duodenal Ulcer", 
                "Gastritis", 
                "Stomach Ulcer", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  Subject: The patient of gastritis, gastric ulcer, and duodenal ulcer infected with\n           Helicobacter pylori\n\n        -  170 subjects per group\n\n        -  Eradication regimens are as follows: AOC group, treated with amoxicillin, rabeprazole,\n           clarithromycin for 7 days; AOM group, treated with amoxicillin, rabeprazole,\n           metronidazole for 7 days; sequential group, treated with amoxicillin, rabeprazole for 5\n           day, followed by clarithromycin, metronidazole, rabeprazole for 5 days; concomitant\n           group, treated with amoxicillin, clarithromycin, metronidazole, rabeprazole for 7 days"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients infected with Helicobacter pylori\n\n        Exclusion Criteria:\n\n          -  cancer\n\n          -  pregnancy\n\n          -  formerly treated with eradication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "540", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01922765", 
            "org_study_id": "concomitant"
        }, 
        "intervention": {
            "arm_group_label": [
                "AOC group", 
                "AOM group", 
                "Sequential group", 
                "concomitant group"
            ], 
            "intervention_name": "amoxicillin, clarithromycin, metronidazole, rabeprazole", 
            "intervention_type": "Drug", 
            "other_name": [
                "AOC group: treated with amoxicillin, rabeprazole, clarithromycin for 7 days", 
                "AOM group: treated with amoxicillin, rabeprazole, metronidazole for 7 days", 
                "Sequential group: treated with amoxicillin, rabeprazole for 5 day, followed by clarithromycin, metronidazole, rabeprazole for 5 days", 
                "concomitant group: treated with amoxicillin, clarithromycin, metronidazole, rabeprazole for 7 days"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Amoxicillin", 
                "Clarithromycin", 
                "Metronidazole", 
                "Rabeprazole"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Helicobacter", 
            "Eradication"
        ], 
        "lastchanged_date": "February 9, 2014", 
        "location": {
            "contact": {
                "email": "jikim@catholic.ac.kr", 
                "last_name": "Jin Il Kim, MD,PhD", 
                "phone": "82-10-6345-9977"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "150-713"
                }, 
                "name": "Yeouido St. Mary's Hospital"
            }, 
            "investigator": {
                "last_name": "Jin Il Kim, MD,PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Education, Science, and Technology", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "measure eradication rate of H.pylori with urea breath test(UBT) after 6 to 8 weeks of treatment", 
            "measure": "Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori", 
            "safety_issue": "No", 
            "time_frame": "6 months (Feb 2014)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01922765"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Catholic University of Korea", 
            "investigator_full_name": "Jin Il Kim", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The Catholic University of Korea", 
        "sponsors": {
            "collaborator": {
                "agency": "St.Vincent Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "The Catholic University of Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}